Omya Showcases New Excipient at CPhI
Omya will showcase its new excipient, Omyapharma, during CPhI Worldwide 2016.
During CPhI 2016 in Barcelona, Spain, Omya, the global producer of calcium carbonate, will showcase Omyapharm, its newly developed pharmaceutical excipient (booth 4F77SSP). The functionalized calcium carbonate can be used in multiple applications, such as orally dispersible granules (ODGs) or tablets (ODTs) that offer high mechanical strength.
Omyapharm is manufactured from high purity natural calcium carbonate using a surface recrystallization process. The external lamellae of the particles provide interlocking contact points. After drug loading, Omyapharm orally dispersible granules can be directly compressed into ODTs, which keep and preserve the active substances and disintegrate in less than 10 seconds. The high porosity of ODTs formulated with Omyapharm makes disintegration rapid and even. With their high mechanical strength, tablets formulated with Omyapharm as an excipient can be filled in regular bottles and blisters, which significantly reduces the cost of packaging.
Source: Omya
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
